Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Management of Inflammatory Bowel Disease During Covid-19 Pandemic. a Practical Review



Aletaha N1 ; Taher M1 ; Daryani NE1 ; Miroliaee A1 ; Avanaki FA1
Authors

Source: Govaresh Published:2020

Abstract

From mid-December of 2019 a newly diagnosed Corona virus with a highly human to human transmission rate was discovered in china which rapidly involved many countries and became pandemic. Although most infected cases are mild but this virus can cause severe lung injury which lead to severe mortality and morbidity. The mortality rate of this virus is high in immunosuppressed patient or with previous medical disorder. Many Inflammatory bowel disease patient are using immunosuppressive or immunomodulating agents which has raised the concern of severe disease in these patients. In this review we are going to discuss about treatment challenges in these patients. © 2020 Iranian Association of Gastroenterology and Hepatology. All rights reserved.
Related Docs
View other Related Docs
1. Pathophysiology of Covid-19 Infection: What Is the Novel Coronavirus (Sars-Cov-2) Doing to Body? a Comprehensive Systematic Review, Reviews and Research in Medical Microbiology (2021)
2. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
3. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
Experts (# of related papers)
View all Related Experts
Amir Reza Radmard (1)
Reza Malekzadeh (1)
Other Related Docs
4. Recent Advances in Antibody-Based Immunotherapy Strategies for Covid-19, Journal of Cellular Biochemistry (2021)
5. A Supporting System for Management of Patients With Inflammatory Bowel Disease During Covid-19 Outbreak: Iranian Experience-Study Protocol, Middle East Journal of Digestive Diseases (2020)
6. Recent Advances in Passive Immunotherapies for Covid-19: The Evidence-Based Approaches and Clinical Trials, International Immunopharmacology (2022)
7. Factors Associated With Covid-19 Morbidity and Mortality: A Narrative Review, Journal of Iranian Medical Council (2020)
8. Lung Transplantation As a Way to Escape Pneumonia in Patients With Covid-19: Lessons From Ards and Influenza, Acta Medica Indonesiana (2021)
9. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
10. A Review on an Ongoing Pandemic Caused by the Severe Acute Respiratory Syndrome Coronavirus 2: The Pathogenesis, Epidemiology, Immunological Features, and Currently Available Diagnostic Tests, Reviews and Research in Medical Microbiology (2022)
11. Covid-19: Features, Clinical Course and Concerns, Journal of Cellular and Molecular Anesthesia (2020)
12. Clinical Symptoms and Types of Samples Are Critical Factors for the Molecular Diagnosis of Symptomatic Covid-19 Patients: A Systematic Literature Review, International Journal of Microbiology (2021)
13. Covid-19: Significance of Antibodies, Human Antibodies (2020)
14. The Role of Cytokines and Their Antagonists in the Treatment of Covid-19 Patients, Reviews in Medical Virology (2023)
15. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
16. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
17. A Comprehensive Review of Histopathological Findings of Infections Induced by Covid-19, Cellular and Molecular Biology (2020)
18. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
19. The Persistence Time of Sars-Cov-2 Rna in Hospitalized Covid-19 Patients: A Prospective Study, Infectious Disorders - Drug Targets (2022)
20. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)